Lung Cancer & Microplastics: A study presented at the European Respiratory Society meeting found microplastics in 66% of lung cancer patients’ lung fluid samples versus 46% in cancer-free patients, with higher particle burdens in cancer cases—though researchers say it’s still unclear whether plastics cause cancer or diseased lungs retain more. Medical Trial Update: Final results from the PAPILLON phase III trial report durable benefit and the longest median overall survival yet for a subset of lung cancer patients treated with amivantamab plus chemotherapy (median 34.3 months). Public Health & Research: A phase 1 clinical trial is set to begin for the first leishmaniasis vaccine, targeting cutaneous leishmaniasis that affects up to 1 million people yearly. AI for Research & Industry: Sheffield Hallam launched a Centre of Excellence in AI and Robotics focused on “responsible AI,” while IIT Madras is rolling out an AI Studio to help researchers and entrepreneurs turn AI research into startups. Higher Ed Policy: A US judge postponed stricter Trump-era visa limits for foreign students and journalists, and India’s Delhi University extended its 2026 PhD registration deadline to Sept. 16 for eligible four-year undergrads. Student Life & Support: UVic redesigned its computer science degree for an AI-forward era, and XJTLU added a Learning Path Mentor plus new 2026 programmes. Campus Safety & Rights: A lawsuit filed by Mahmoud Khalil accuses Columbia University of discrimination and failing to protect Palestinian students amid harassment and doxxing.